baber/WOPTO huggingface dataset:
Patent MX-2019009315-A (MX)
Title: A moisture-curable adhesive composition and a method for mounting tiles on wall surfaces.
Inventor: TODD V PORTER
IPC: C08K7/08
Filed: 2018-02-05
Abstract: A moisture-curable adhesive composition comprises a polymer component selected from a silane-terminated polyalkylene oxide and/or a polyurethane; a plurality of amino-silane modified wollastonite fibers having an average aspect ratio of from about 1.5:1 to about 12:1 and an average fiber length of from about 6 µm to about 825 µm; at least two fillers, wherein one of said fillers is untreated and a second of said fillers is treated with a modifier selected from the group consisting of a fatty acid derivative, a silane, a titanate, and mixtures thereof wherein at least one of said fillers is irregularly shaped; and a rheology modifier. The composition preferably further comprises a plurality of irregularly-shaped crumb rubber particles having an average particle size of between about 0.5 to 1.5 mm. The composition is useful for adhering tiles to surfaces, especially large format tiles to substantially vertically-extending wall surfaces.
Patent MX-2019010907-A (MX)
Title: Farnesoid x receptor agonists and uses thereof.
Inventor: STEVEN P GOVEK
IPC: A61K31/426
Filed: 2018-03-14
Abstract: Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Patent MX-2019014425-A (MX)
Title: Target assembly for safe and economic evaporation of brittle materials.
Inventor: SIEGFRIED KRASSNITZER
IPC: C23C14/35
Filed: 2018-05-30
Abstract: The present invention discloses a target assembly which allows safe, fracture-free and economic operation of target materials with low fracture toughness and/or bending strength during arc evaporation processes as well as in sputtering processes. The present invention discloses a target assembly for PVD processes, comprising a target, and a target holding device (20), characterized in that the target (10) comprises a first bayonet lock and the target holding device (20) comprises a counterbody for the first bayonet lock of the target and a second bayonet lock for engaging the target assembly in the cooling means of the deposition chamber.
Patent MX-2019015606-A (MX)
Title: NEW USES OF A PURE 5-HT <sub>6</sub> RECEPTOR ANTAGONIST.
Inventor: NIROGI RAMAKRISHNA
IPC: A61K31/496
Filed: 2018-06-29
Abstract: The present invention relates to new uses of a pure 5-HT6 receptor antagonist, specifically 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperaziny l)methyl]-1H-indole or a pharmaceutically acceptable salts thereof, for the treatment of dementia due to menopause, senile dementia, vascular dementia, chemotherapy-induced cognitive impairment and behavioral changes in dementia such as agitation, aggression, depression, anxiety, psychosis, disinhibition, or sleep disturbances. The present invention further provides use of the said compounds in the manufacture of medicament intended for the treatment of the disorders described herein.
Patent MX-2020001627-A (MX)
Title: Polypropylene composition with low shrinkage at wide application temperature range.
Inventor: GAHLEITNER MARKUS
IPC: C08F210/16
Filed: 2018-08-24
Abstract: The present application relates to a polypropylene composition having a melt flow rate MFR.2 (230 Â°C) measured according to ISO 1133 in the range of 5 to 50 g/10min, to a composition comprising the polypropylene composition and one or more additive(s) in an amount of up to 4 wt.-%, based on the total weight of the composition, to a process for the preparation of the polypropylene composition and an article comprising the polypropylene composition as well as the use of the polypropylene composition for decreasing the brittle-to-ductile transition temperature.
Patent MX-2020006528-A (MX)
Title: Conveyor apparatus and system.
Inventor: SMITH CHRIS
IPC: B65G39/20
Filed: 2020-07-13
Abstract: A conveyor system is provided. Conveyor modules are pivotally secured to one another through engagement of links on a first and second side of each module. Portals extend through the modules. Each portal comprises four portal surfaces oriented in opposing pairs. A radial slot is located on each of at least two portal surfaces. A cup is provided with four walls. Ridges are formed on the outside surfaces of at least two opposing walls of the cup. An orifice is formed on two opposing walls of the cup. A roller is rotatably mounted on an axle that extends between the orifices to position the roller inside the cup. The cup is secured inside the portal by engagement of the ridges with the slots. The cup and roller assembly may be rotated to change its orientation relative to the module.
Patent MX-2020008015-A (MX)
Title: Combination therapy for the treatment of mastocytosis.
Inventor: FLYNN DANIEL L
IPC: A61K31/155
Filed: 2019-01-31
Abstract: The present disclosure relates to the use of l-[4-bromo-5-[l-ethyl-7-(methylamino)-2-oxo-l,2-dihydro-l,6-nap hthyridin-3-yl]-2-fluorophenyl]-3-phenylurea or l-(5-(7-amino-l-ethyl-2-oxo-l,2-dihydro-l,6-naphthyridin-3-yl)- 4-bromo-2-fluorophenyl)-3-phenylurea, or a pharmaceutically acceptable salt thereof, in combination with a MAPKAP pathway inhibitor such as for example a RAS, RAF, MEK, or ERK inhibitor for the treatment of mastocytosis.
Patent MX-2020009850-A (MX)
Title: Vehicle traffic control device.
Inventor: MARTINEZ VELAZQUEZ GUSTAVO
IPC: E01F13/06
Filed: 2020-09-21
Abstract: The present invention relates to a vehicle traffic control device, comprising a transmission system with a first rotating shaft that receives manual or mechanical movement generating a spin and a second rotating shaft spinning in the opposite direction, receiving transmission through a gear system. The said second shaft comprises a head with a cross-section at 45°, defining a slanted face with an elliptical track, coupling an axial bearing and an internal cavity. Said upper end adapts with a groove for penetrating and fitting into the inner grooved hollow of a CV joint. Said CV joint positions with the same inclination as the second rotating shaft with a boom comprising a fixing base with an undercut with the same tendency as said CV joint covering it and the axial bearing.
Patent MX-2020010653-A (MX)
Title: Anti-pd-l1 antibody and use thereof.
Inventor: LI BOHUA
IPC: C12N15/63
Filed: 2018-08-27
Abstract: Provided are an antibody that binds to the PD-L1 protein or CD137 protein, an antigen-binding fragment or a variant thereof, as well as a bispecific antibody that can bind to both the PD-L1 protein and the CD137 protein. The bispecific antibody has a strong ability to specifically recognize the PD-L1 protein and the CD137 protein, and can enhance T-cell activity. Also provided is the use of the antibody or the antigen-binding fragment or the variant thereof and the bispecific antibody in the prevention and treatment of tumors.Provided are an antibody that binds to the PD-L1 protein or CD137 protein, an antigen-binding fragment or a variant thereof, as well as a bispecific antibody that can bind to both the PD-L1 protein and the CD137 protein. The bispecific antibody has a strong ability to specifically recognize the PD-L1 protein and the CD137 protein, and can enhance T-cell activity. Also provided is the use of the antibody or the antigen-binding fragment or the variant thereof and the bispecific antibody in the prevention and treatment of tumors. The present invention relates to the field of pharmaceutical synthesis, in particular to a method for preparing a hexahydrofuro-furanol derivative, an intermediate thereof and a preparation method therefor. The preparation method comprises steps of a halogenation reaction, an acylation reaction, an enzymatic reduction reaction, a reaction with amine compounds, and a reductive cyclization reaction, (A1, A2, B, Cp1, C<sub>L</sub>, Cf) wherein R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub> are hydrogen or a hydroxyl protection group; and R<sub>4</sub> and R<sub>5</sub> are the same or different phenyls, alkyls or substituted phenyls. During the preparation process for the hexahydrofuro-furanol derivative, an enzymatic method is used to construct chirality, and by using such a technical means, products with very high optical purity can be prepared. The preparation method can produce and prepare a key intermediate, (3R, 3aS, 6aR)-hexahydrofuro[2, 3-b]-3-ol, of Darunavir, and is a very economic method suitable for industrial production.
Patent MX-2020010914-A (MX)
Title: Pyrazo-tetrahydroisoquinoline derivatives as dopamine d1 receptor positive modulators.
Inventor: COATES DAVID ANDREW
IPC: A61P25/16
Filed: 2019-04-17
Abstract: The invention provides certain (phenyl)-(pyrazol)-3,4-dihydroisoquinolin-2(1H)- yl)ethan-1-one compounds of formula I as D1 positive allosteric modulators (PAMs), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I, or a pharmaceutically acceptable salt thereof, to treat certain symptoms of Parkinson's disease, schizophrenia, ADHD or Alzheimer's disease.
Patent MX-2020014288-A (MX)
Title: Artificial intelligence-based base calling.
Inventor: JAGANATHAN KISHORE
IPC: G16B40/10
Filed: 2020-03-21
Abstract: The technology disclosed processes input data through a neural network and produces an alternative representation of the input data. The input data includes per-cycle image data for each of one or more sequencing cycles of a sequencing run. The per-cycle image data depicts intensity emissions of one or more analytes and their surrounding background captured at a respective sequencing cycle. The technology disclosed processes the alternative representation through an output layer and producing an output and base calls one or more of the analytes at one or more of the sequencing cycles based on the output.
Patent MX-2021004216-A (MX)
Title: Fire suppression fluid containing a carboxylate salt.
Inventor: BAKER MARK R
IPC: A62D1/00
Filed: 2019-10-11
Abstract: An aqueous fire sprinkler fluid containing a C4 or greater carboxylate salt for freezing point depression is described. The salts may be used in conjunction with glycols. The salts decrease the combustibility and give lower viscosity than higher glycol fluids, both benefitting fire sprinkler systems. These salt solutions are friendly to metal and CPVC pipes and are thus useful for fire sprinkler systems by not causing environmental stress cracking of the CPVC components and not being corrosive to the metal parts.
Patent MX-2021007834-A (MX)
Title: Pallet sled and delivery system.
Inventor: KALINOWSKI DANE GIN MUN
IPC: B60G7/00
Filed: 2021-06-25
Abstract: A pallet sled includes a pair of tines extending forward from a base. A load wheel supports each of the pair of tines. The load wheels are each configured to move away from the respective tine to lift the respective tine upward relative to a support surface on which the load wheel is supported. A processor on the pallet sled records usage of the sled, such as lift cycles, location over time, battery condition, lift height, weight lifted, distance traveled, and the like. A communication circuit may be configured to send data from the pallet sled to a remote server. An identification reader may be configured to read an identification tag of an object supported on the pair of tines, such as an rfid tag on a pallet.
Patent MX-2021008578-A (MX)
Title: Formulations.
Inventor: JOHNSON ANDY
IPC: A61K47/12
Filed: 2020-01-16
Abstract: The present invention relates to a pharmaceutical formulation comprising (i) a therapeutically effective amount of a bispecific protein comprising a soluble T cell receptor (TCR) and an scFV; and (ii) a surfactant. The w/w ratio of surfactant to protein is in the range of 0.75:1 to 1.5:1. The formulation may further comprise a bulking agent and/or a stabiliser. A further pharmaceutical formulation comprises (i) a therapeutically effective amount of a bispecific protein comprising a soluble T cell receptor (TCR) and an scFV; (ii) a bulking agent; and (iii) a stabiliser. The w/w ratio of stabiliser to bulking agent may be greater than 1:1.
Patent MX-2021010457-A (MX)
Title: Method for the in vivo synthesis of 4-hydroxymethylfurfural and derivatives thereof.
Inventor: RADUAN ALEXANDRINO PAULO MOISES
IPC: C12N9/16
Filed: 2020-03-02
Abstract: The present disclosure provides recombinant microorganisms and methods for the production of 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA from a carbon source. The method provides for engineered microorganisms that express endogenous and/or exogenous nucleic acid molecules that catalyze the conversion of a carbon source into 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA. The disclosure further provides methods of producing polymers derived from 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA.
Patent MX-2021012126-A (MX)
Title: Compositions and methods for inhibiting gene expression in the central nervous system.
Inventor: WANG WEIMIN
IPC: C12N15/113
Filed: 2020-04-03
Abstract: This disclosure relates to the use of RNA oligonucleotides, compositions and methods useful for reducing ALDH2 or other target gene expression, in the central nervous system. In some embodiments, the oligonucleotide is used in methods of treating neurological diseases. Stable oligonucleotide derivatives that have enhanced activity in the central nervous system are provided.
Patent MX-2021012185-A (MX)
Title: Sheath-bonding link box.
Inventor: BURKS STEPHEN
IPC: H02B1/28
Filed: 2020-04-03
Abstract: A sheath-bonding link box is provided, the sheath-bonding link box including a housing defining a sealed interior space, and a set of electrically conductive connectors extending through the housing between an exterior of the enclosure and the interior space. The set of connectors each has an internal portion positioned inside of the interior space and an external portion positioned outside of the housing. The internal portion of the connectors is electrically connectable to a functional link in the interior space, and the external portion of the connectors is dimensioned to be electrically connectable to a sheath-bonding lead.
Patent MX-2021012756-A (MX)
Title: Btk inhibitor ring derivative, preparation method therefor and pharmaceutical application thereof.
Inventor: YE FEI
IPC: A61K31/395
Filed: 2020-05-29
Abstract: A BTK inhibitor ring derivative, a preparation method therefor and a pharmaceutical application thereof. The BTK inhibitor ring derivative is a compound represented by a general formula (I) or a stereoisomer, a solvate, a prodrug, a metabolite, a pharmaceutically acceptable salt or co-crystal thereof, and the BTK inhibitor ring derivative is used to treat BTK-related diseases such as tumors or autoimmune system diseases.
Patent MX-2021013811-A (MX)
Title: System and method for video coding.
Inventor: LIM CHONG SOON
IPC: H04N19/176
Filed: 2020-05-15
Abstract: An encoder includes circuitry and memory coupled to the circuitry. The circuitry determines whether to split a current luma virtual pipeline decoding unit (VPDU) into smaller blocks. When it is determined not to split the current luma VPDU into smaller blocks, the circuitry predicts a block of chroma samples without using luma samples. When it is determined to split the luma VPDU into smaller blocks, the circuitry predicts the block of chroma samples using luma samples. The circuitry encodes the block using the predicted chroma samples.
Patent MX-2021013974-A (MX)
Title: Tl1a patient selection methods, systems, and devices.
Inventor: LI DALIN
IPC: C12Q1/6883
Filed: 2020-05-13
Abstract: Provided are methods, systems, and kits for selecting a patient for treatment with a therapeutic agent based on a presence of a genotype associated with a positive therapeutic response to the therapeutic agent. The therapeutic agent, in some embodiments, is an inhibitor of TL1A activity or expression, such as for example, an anti-TL1A antibody.
Patent MX-2021014096-A (MX)
Title: Heterocyclic compounds, preparation methods and uses thereof.
Inventor: SHI ZHE
IPC: A61K31/519
Filed: 2020-05-20
Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting KRAS G12C in a cell, and/or in treating various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (e.g., non-small cell lung cancer).
Patent MX-2021014664-A (MX)
Title: A method and apparatus for processing water treatment residuals.
Inventor: RUSSELL MARK
IPC: C04B28/16
Filed: 2020-06-12
Abstract: A method for processing water treatment residuals, or other amorphous aluminium oxide or aluminium hydroxide rich waste residuals, for use in the manufacture of hydraulic binders, comprising heating the residuals to remove water and oxidise organic material contained therein, comprising controlling the temperature of the residuals during heating such that they are heated to a temperature no higher than 800Â°C, more preferably no higher than 650Â°C, to ensure that aluminium compounds in the WTR, in particular aluminium oxide and aluminium hydroxide, remain in an amorphous state. The method may comprise controlling the temperature of the water treatment residuals such that they are heated to a temperature between 350Â°C and 650Â°C, more preferably between 400Â°C and 500Â°C.
Patent MX-2022003776-A (MX)
Title: Off-road vehicle.
Inventor: DECKARD AARON D
IPC: B60F5/00
Filed: 2022-03-29
Abstract: A vehicle shown herein is a side by side utility vehicle having frame configured to effectively transfer various loads throughout the frame as whole. The vehicle may further or alternatively include a routing tray configured to retain various fluid lines of the vehicle, a transmission including a passive duct acoustical attenuation device, a door seal configured to allow the frame to contact the seal at an angle, a modular door actuating mechanism, and/or a modular skid plate.
Patent MX-2022005717-A (MX)
Title: Anti-siglec-9 antibody molecules.
Inventor: LÄUBLI HEINZ
IPC: C07K16/28
Filed: 2020-11-13
Abstract: Anti-Siglec-9 antibody molecules or binding fragments thereof are disclosed. These Anti-Siglec-9 antibody molecules or binding fragments can be used to treat cancer, acute or chronic hepatitis B.
Patent MX-2022007116-A (MX)
Title: Anti-c5 antibody for the treatment of neuromyelitis optica spectrum disorder.
Inventor: O'Brien Fanny
IPC: C07K16/18
Filed: 2020-12-08
Abstract: Provided are methods for clinical treatment of neuromyelitis optica spectrum disorder (NMOSD) using an anti-C5 antibody, or antigen binding fragment thereof.
Patent MX-2022011032-A (MX)
Title: Coating formulation for curtain coating fibrous non-woven mats.
Inventor: HUIN VINCENT
IPC: C09D5/02
Filed: 2021-03-09
Abstract: A coated non-woven fibrous mat is disclosed comprising a non-woven precursor mat including a plurality of randomly oriented fibers bound by a precursor binder composition, The non-woven fibrous precursor mat has a first major surface and a second major surface opposite to and having a surface roughness greater than the first surface, defining a thickness therebetween. A coating composition is applied to the second major surface of the non-woven precursor mat and substantially uniformly penetrates 5% to less than 30% of the thickness of the non-woven precursor mat. The coating composition comprises a mineral filler and an organic latex binder composition. The coating composition is applied to the non-woven precursor mat in an amount between 1.0 and 10.0 lbs/100 ft2.
Patent MX-2022012889-A (MX)
Title: Method and apparatus for transmitting synchronization/physical broadcast channel block.
Inventor: ZHANG JIAYIN
IPC: H04W56/00
Filed: 2021-04-14
Abstract: Provided are a method and apparatus for transmitting an SS/PBCH block. The method comprises: a terminal device receiving an SS/PBCH block in an SS/PBCH block burst set, and then obtaining indication information according to the SS/PBCH block, wherein the indication information can be used for indicating a candidate index of at least one SS/PBCH block in the SS/PBCH block burst set, and the number of candidate indexes is greater than 64, for example, there may be 128, 160, 180, 196, 240, etc., candidate indexes. A network device may not be limited to 64 candidate indexes, that is, candidate positions used for sending SS/PBCH blocks are not limited to 64, and thus, the network device can send a greater number of SS/PBCH blocks for a terminal device.
Patent MX-2022014455-A (MX)
Title: Stable anti-clever-1 antibody formulation.
Inventor: VAINIO MARITA
IPC: A61K39/395
Filed: 2021-06-14
Abstract: The invention relates to stable formulations comprising ananti-CLEVER-1 antibody or antigen binding fragment(s)thereof, a buffer and a stabilizing agent. The present invention further relates to stable formulations of an anti-CLEVER-1 antibody or antigen binding fragments thereof for use in treatment of various diseases and disorders.
Patent MX-2022015582-A (MX)
Title: Compositions and methods for parasite control.
Inventor: MAZUROV ANATOLY
IPC: C07D453/06
Filed: 2021-06-23
Abstract: The present invention relates in its broadest aspect to a compound of Formula I as provided herein, formulations comprising such a compound and corresponding uses thereof for the reduction of infestation with ectoparasites, in particular ectoparasites of the insect class, including fleas and mosquitoes and/or ectoparasites of the arachnid class, including ticks and mites, etc. Also provided herein are methods for preparing the formulations of the invention and methods for controlling ectoparasites using the compounds and/or formulations provided herein.
Patent MX-2022016438-A (MX)
Title: Microencapsulated tcmtb.
Inventor: SEGRET PONS ROGER
IPC: A01N25/28
Filed: 2021-06-28
Abstract: The invention relates to a new process for preparing microencapsulated thiocyanomethylthio benzothiazole (TCMTB) by covering TCMTB droplets in an emulsion of an organic phase in an aqueous phase with a melamine-formaldehyde polymer coating to form solid TCMTB microcapsules. The invention further relates to the new TCMTB microcapsules and aqueous suspensions containing the TCMTB microcapsules and the use of microencapsulated TCMTB in tanning or for preserving hides, leather, fibers and polymerized material or for preserving paints, paper products, wood, wood products, or industrial water.
Patent MX-PA00005194-A (MX)
Title: Process for the synthesis of finely divided antiperspirant active ingredient suspensions.
Inventor: JOHANNES BREKER
IPC: C01F7/57
Filed: 2000-05-26
Abstract: Finely divided antiperspirant suspension preparation comprises mixing a mixed aluminum hydroxide/halide salt with an optional buffer material in a non-aqueous oil phase and grinding. Preparation of a finely divided antiperspirant suspension comprises mixing a mixed aluminum hydroxide/halide salt of formula Al(OH)(3-b)XbzH2O with an optional buffer material in a non-aqueous oil phase and ground at 80 degrees C to the required fineness. b = 0.4-3, preferably 0.45-1.0; z = below 4; X = halogen, preferably Cl. An Independent claim is included for a perspiration-hindering cosmetic preparation containing the above suspension as active component.
Patent MX-PA01001232-A (MX)
Title: A process for preparing a catalyst and catalytic oxidation therewith.
Inventor: MANHUA LIN
IPC: B01J37/04
Filed: 2001-02-01
Abstract: A process useful for the catalytic gas phase oxidation of alkanes to unsaturated aldehydes or carboxylic acids uses catalysts of particular compositions formed in a particular manner.